Semler Scientific has offered to pay the Department of Justice nearly $30 million to settle federal health care fraud claims ...

April is National Minority Health Month, a time dedicated to acknowledging health disparities that affect minority ...

Peripheral artery disease, also known as PAD, is a condition in which the narrowing of the arteries causes poor blood flow to ...

Treatment with semaglutide improved maximum walking distance in patients with type 2 diabetes (T2D) and symptomatic peripheral artery disease (PAD), according to results from the STRIDE trial ...

Less commonly, the pain—referred to as axillary pain—may be due to an autoimmune or arterial disease, nerve compression ... There may be one or several lumps, which move easily with slight finger ...

A new Intermountain Health study finds that peripheral artery disease, a condition that affects more than 10 million Americans over the age of 40, is often underdiagnosed and undertreated ...

A new Intermountain Health study finds that peripheral artery disease, a condition that affects more than 10 million Americans over the age of 40, is often underdiagnosed and undertreated ...

Novo Nordisk (NVO) announced on Saturday that a late-stage trial for its popular weight loss therapy Ozempic in adults with type 2 diabetes and a vascular disorder known as peripheral artery ...

Semaglutide, a GLP-1 receptor agonist, improves glycaemic control and cardiovascular outcomes in patients with type 2 diabetes and those with cardiovascular disease, including peripheral artery ...

Those outcomes included heart attack, stroke, unstable angina (chest pain that results from restricted blood flow to the heart), peripheral arterial disease (narrowed blood vessels in the arms or ...

Bonaca MC, Catarig AM, Houlind K, et al., for the STRIDE Trial Investigators. Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes (STRIDE): a ...